• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Amazon’s Acquisition of Irobot Under Investigation in the Uk

Share:

April 11, 2023

The Competition and Markets Authority in the UK has begun inviting comments on Amazon’s proposed acquisition of Roomba-maker iRobot Corporation, citing the merger’s potential “lessening of competition within any market or markets in the United Kingdom for goods or services”. Regulators in the EU and US are also currently examining the deal. Amazon agreed to acquire iRobot for $1.7bn in August 2022.

Amazon’s AMZN proposed acquisition of Roomba-maker iRobot Corporation IRBT is under regulatory scrutiny in the UK.

The Competition and Markets Authority indicated on Thursday that it has opened an invitation to comment in consideration of the merger’s potential “lessening of competition within any market or markets in the United Kingdom for goods or services,” the regulator said on its website.

“We are excited about the opportunity to bring together our experience and iRobot’s great products to benefit customers who have many options to choose from when they buy a vacuum,” an Amazon spokesperson told Seeking Alpha in an email. “We’re working cooperatively with the relevant regulators in their review of the merger.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Amazon AMZN first agreed to acquire iRobot for $61/share in an all-cash transaction valued at about $1.7B in August 2022. The stock has traded well below that price in the months following the announcement as regulators in the EU, US, and now UK probe the transaction.

Legal watchdogs in the UK have urged national authorities to look into the deal since late 2022.

Politico reported last month that Federal Trade Commission’s staff attorneys are leaning toward filing a lawsuit to block the deal. A lawsuit to block the purchase of the Roomba maker could come in the next few months.

iRobot IRBT received a second request to do a more in-depth review from the FTC in September. In October Sen. Elizabeth Warren (D-MA) as well as five other members of Congress urged the FTC to block the transaction. In February the Financial Times reported that Europe’s antitrust regulator is likely to start a formal probe into the iRobot IRBT deal.

Source: SeekingAlpha

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Google Develops Search Tools for COVID-19 Resources in IndiaGoogle Develops Search Tools for COVID-19 Resources in India
  • Evotec Adds Cell Therapy Manufacturing Facility with Acquisition of RigenerandEvotec Adds Cell Therapy Manufacturing Facility with Acquisition of Rigenerand
  • Plandai Biotechnologies, Inc. Announces Termination of Asset Acquisition Agreement with EV Hotel, Updates on Status of Independent AuditPlandai Biotechnologies, Inc. Announces Termination of Asset Acquisition Agreement with EV Hotel, Updates on Status of Independent Audit
  • Shire : Takeda`s proposed takeover of Shire receives conditional EU clearanceShire : Takeda`s proposed takeover of Shire receives conditional EU clearance
  • Centene’s Illinois Subsidiary to Acquire Membership of NextLevel Health PartnersCentene’s Illinois Subsidiary to Acquire Membership of NextLevel Health Partners
  • Healthcare M&A Weekly Three Major DealsHealthcare M&A Weekly Three Major Deals
  • The Way Drugs Are Sold & Distributed Is Opaque, Inefficient, & Costly. Here’s How Companies Are Trying To Fix That.The Way Drugs Are Sold & Distributed Is Opaque, Inefficient, & Costly. Here’s How Companies Are Trying To Fix That.
  • Intel Launches $50M Pandemic Response Technology Initiative to Combat CoronavirusIntel Launches $50M Pandemic Response Technology Initiative to Combat Coronavirus

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications